- Home
- ATLO vs OBIO Comparison
ATLO vs OBIO Comparison
Compare ATLO & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- OBIO
- Stock Information
- Founded
- ATLO 1903
- OBIO 2017
- Country
- ATLO United States
- OBIO United States
- Employees
- ATLO N/A
- OBIO N/A
- Industry
- ATLO Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- ATLO Finance
- OBIO Health Care
- Exchange
- ATLO Nasdaq
- OBIO Nasdaq
- Market Cap
- ATLO 180.3M
- OBIO 172.1M
- IPO Year
- ATLO N/A
- OBIO N/A
- Fundamental
- Price
- ATLO $20.76
- OBIO $3.55
- Analyst Decision
- ATLO
- OBIO Strong Buy
- Analyst Count
- ATLO 0
- OBIO 4
- Target Price
- ATLO N/A
- OBIO $14.00
- AVG Volume (30 Days)
- ATLO 23.2K
- OBIO 368.8K
- Earning Date
- ATLO 10-17-2025
- OBIO 11-12-2025
- Dividend Yield
- ATLO 3.85%
- OBIO N/A
- EPS Growth
- ATLO 82.22
- OBIO N/A
- EPS
- ATLO 1.79
- OBIO N/A
- Revenue
- ATLO $60,568,000.00
- OBIO $2,944,000.00
- Revenue This Year
- ATLO N/A
- OBIO $29.26
- Revenue Next Year
- ATLO N/A
- OBIO $10.65
- P/E Ratio
- ATLO $11.94
- OBIO N/A
- Revenue Growth
- ATLO 18.60
- OBIO 41.61
- 52 Week Low
- ATLO $15.75
- OBIO $2.20
- 52 Week High
- ATLO $21.48
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- ATLO 55.69
- OBIO 57.31
- Support Level
- ATLO $19.56
- OBIO $3.56
- Resistance Level
- ATLO $21.00
- OBIO $4.10
- Average True Range (ATR)
- ATLO 0.46
- OBIO 0.32
- MACD
- ATLO 0.10
- OBIO -0.01
- Stochastic Oscillator
- ATLO 63.16
- OBIO 52.88
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.